カテゴリー： QYResearch, 世界, 医療/バイオ

世界の血液透析濃縮物市場インサイト及び予測（重炭酸塩濃縮物、酸濃縮物）

◆英語タイトル：Global Haemodialysis Concentrates Market Insights, Forecast to 2028
	◆商品コード：QY22JLX09500 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2022年7月（※2025年版があります。お問い合わせください。） ◆ページ数：107 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥744,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,117,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,489,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、血液透析濃縮物のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に血液透析濃縮物の世界市場のxxx％を占める「重炭酸塩濃縮物」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「透析センター」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
血液透析濃縮物の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの血液透析濃縮物市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

血液透析濃縮物のグローバル主要企業には、Rockwell Medical、Nipro、MEDIVATORS、Dialysis Medical Solutions、Fresenius Medical Care、Baxter、B. Braun、Renacon Pharma、Surni Group、Weigao Group、BIOLIGHT、Taishikangなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

血液透析濃縮物市場は、種類と用途によって区分されます。世界の血液透析濃縮物市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
重炭酸塩濃縮物、酸濃縮物

【用途別セグメント】
透析センター、在宅透析、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 血液透析濃縮物製品概要
- 種類別市場（重炭酸塩濃縮物、酸濃縮物）
- 用途別市場（透析センター、在宅透析、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の血液透析濃縮物販売量予測2017-2028
- 世界の血液透析濃縮物売上予測2017-2028
- 血液透析濃縮物の地域別販売量
- 血液透析濃縮物の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別血液透析濃縮物販売量
- 主要メーカー別血液透析濃縮物売上
- 主要メーカー別血液透析濃縮物価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（重炭酸塩濃縮物、酸濃縮物）
- 血液透析濃縮物の種類別販売量
- 血液透析濃縮物の種類別売上
- 血液透析濃縮物の種類別価格
・用途別市場規模（透析センター、在宅透析、その他）
- 血液透析濃縮物の用途別販売量
- 血液透析濃縮物の用途別売上
- 血液透析濃縮物の用途別価格
・北米市場
- 北米の血液透析濃縮物市場規模（種類別、用途別）
- 主要国別の血液透析濃縮物市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの血液透析濃縮物市場規模（種類別、用途別）
- 主要国別の血液透析濃縮物市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の血液透析濃縮物市場規模（種類別、用途別）
- 主要国別の血液透析濃縮物市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の血液透析濃縮物市場規模（種類別、用途別）
- 主要国別の血液透析濃縮物市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの血液透析濃縮物市場規模（種類別、用途別）
- 主要国別の血液透析濃縮物市場規模（トルコ、サウジアラビア）
・企業情報
Rockwell Medical、Nipro、MEDIVATORS、Dialysis Medical Solutions、Fresenius Medical Care、Baxter、B. Braun、Renacon Pharma、Surni Group、Weigao Group、BIOLIGHT、Taishikang
・産業チェーン及び販売チャネル分析
- 血液透析濃縮物の産業チェーン分析
- 血液透析濃縮物の原材料
- 血液透析濃縮物の生産プロセス
- 血液透析濃縮物の販売及びマーケティング
- 血液透析濃縮物の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 血液透析濃縮物の産業動向
- 血液透析濃縮物のマーケットドライバー
- 血液透析濃縮物の課題
- 血液透析濃縮物の阻害要因
・主な調査結果

Market Analysis and Insights: Global Haemodialysis Concentrates Market
Due to the COVID-19 pandemic, the global Haemodialysis Concentrates market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Bicarbonate Concentrates accounting for % of the Haemodialysis Concentrates global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Dialysis Center segment is altered to an % CAGR throughout this forecast period.
China Haemodialysis Concentrates market size is valued at US$ million in 2021, while the US and Europe Haemodialysis Concentrates are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Haemodialysis Concentrates landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Haemodialysis Concentrates include Rockwell Medical, Nipro, MEDIVATORS, Dialysis Medical Solutions, Fresenius Medical Care, Baxter, B. Braun, Renacon Pharma and Surni Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Haemodialysis Concentrates Scope and Segment
Haemodialysis Concentrates market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Haemodialysis Concentrates market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Bicarbonate Concentrates
Acid Concentrates
Segment by Application
Dialysis Center
Home Dialysis
Others
By Company
Rockwell Medical
Nipro
MEDIVATORS
Dialysis Medical Solutions
Fresenius Medical Care
Baxter
B. Braun
Renacon Pharma
Surni Group
Weigao Group
BIOLIGHT
Taishikang
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Haemodialysis Concentrates Product Introduction
1.2 Market by Type
1.2.1 Global Haemodialysis Concentrates Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Bicarbonate Concentrates
1.2.3 Acid Concentrates
1.3 Market by Application
1.3.1 Global Haemodialysis Concentrates Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Dialysis Center
1.3.3 Home Dialysis
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Haemodialysis Concentrates Sales Estimates and Forecasts 2017-2028
2.2 Global Haemodialysis Concentrates Revenue Estimates and Forecasts 2017-2028
2.3 Global Haemodialysis Concentrates Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Haemodialysis Concentrates Sales by Region
2.4.1 Global Haemodialysis Concentrates Sales by Region (2017-2022)
2.4.2 Global Sales Haemodialysis Concentrates by Region (2023-2028)
2.5 Global Haemodialysis Concentrates Revenue by Region
2.5.1 Global Haemodialysis Concentrates Revenue by Region (2017-2022)
2.5.2 Global Haemodialysis Concentrates Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Haemodialysis Concentrates Sales by Manufacturers
3.1.1 Global Top Haemodialysis Concentrates Manufacturers by Sales (2017-2022)
3.1.2 Global Haemodialysis Concentrates Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Haemodialysis Concentrates in 2021
3.2 Global Haemodialysis Concentrates Revenue by Manufacturers
3.2.1 Global Haemodialysis Concentrates Revenue by Manufacturers (2017-2022)
3.2.2 Global Haemodialysis Concentrates Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Haemodialysis Concentrates Revenue in 2021
3.3 Global Haemodialysis Concentrates Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Haemodialysis Concentrates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Haemodialysis Concentrates Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Haemodialysis Concentrates Sales by Type
4.1.1 Global Haemodialysis Concentrates Historical Sales by Type (2017-2022)
4.1.2 Global Haemodialysis Concentrates Forecasted Sales by Type (2023-2028)
4.1.3 Global Haemodialysis Concentrates Sales Market Share by Type (2017-2028)
4.2 Global Haemodialysis Concentrates Revenue by Type
4.2.1 Global Haemodialysis Concentrates Historical Revenue by Type (2017-2022)
4.2.2 Global Haemodialysis Concentrates Forecasted Revenue by Type (2023-2028)
4.2.3 Global Haemodialysis Concentrates Revenue Market Share by Type (2017-2028)
4.3 Global Haemodialysis Concentrates Price by Type
4.3.1 Global Haemodialysis Concentrates Price by Type (2017-2022)
4.3.2 Global Haemodialysis Concentrates Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Haemodialysis Concentrates Sales by Application
5.1.1 Global Haemodialysis Concentrates Historical Sales by Application (2017-2022)
5.1.2 Global Haemodialysis Concentrates Forecasted Sales by Application (2023-2028)
5.1.3 Global Haemodialysis Concentrates Sales Market Share by Application (2017-2028)
5.2 Global Haemodialysis Concentrates Revenue by Application
5.2.1 Global Haemodialysis Concentrates Historical Revenue by Application (2017-2022)
5.2.2 Global Haemodialysis Concentrates Forecasted Revenue by Application (2023-2028)
5.2.3 Global Haemodialysis Concentrates Revenue Market Share by Application (2017-2028)
5.3 Global Haemodialysis Concentrates Price by Application
5.3.1 Global Haemodialysis Concentrates Price by Application (2017-2022)
5.3.2 Global Haemodialysis Concentrates Price Forecast by Application (2023-2028)
6 North America
6.1 North America Haemodialysis Concentrates Market Size by Type
6.1.1 North America Haemodialysis Concentrates Sales by Type (2017-2028)
6.1.2 North America Haemodialysis Concentrates Revenue by Type (2017-2028)
6.2 North America Haemodialysis Concentrates Market Size by Application
6.2.1 North America Haemodialysis Concentrates Sales by Application (2017-2028)
6.2.2 North America Haemodialysis Concentrates Revenue by Application (2017-2028)
6.3 North America Haemodialysis Concentrates Market Size by Country
6.3.1 North America Haemodialysis Concentrates Sales by Country (2017-2028)
6.3.2 North America Haemodialysis Concentrates Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Haemodialysis Concentrates Market Size by Type
7.1.1 Europe Haemodialysis Concentrates Sales by Type (2017-2028)
7.1.2 Europe Haemodialysis Concentrates Revenue by Type (2017-2028)
7.2 Europe Haemodialysis Concentrates Market Size by Application
7.2.1 Europe Haemodialysis Concentrates Sales by Application (2017-2028)
7.2.2 Europe Haemodialysis Concentrates Revenue by Application (2017-2028)
7.3 Europe Haemodialysis Concentrates Market Size by Country
7.3.1 Europe Haemodialysis Concentrates Sales by Country (2017-2028)
7.3.2 Europe Haemodialysis Concentrates Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Haemodialysis Concentrates Market Size by Type
8.1.1 Asia Pacific Haemodialysis Concentrates Sales by Type (2017-2028)
8.1.2 Asia Pacific Haemodialysis Concentrates Revenue by Type (2017-2028)
8.2 Asia Pacific Haemodialysis Concentrates Market Size by Application
8.2.1 Asia Pacific Haemodialysis Concentrates Sales by Application (2017-2028)
8.2.2 Asia Pacific Haemodialysis Concentrates Revenue by Application (2017-2028)
8.3 Asia Pacific Haemodialysis Concentrates Market Size by Region
8.3.1 Asia Pacific Haemodialysis Concentrates Sales by Region (2017-2028)
8.3.2 Asia Pacific Haemodialysis Concentrates Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Haemodialysis Concentrates Market Size by Type
9.1.1 Latin America Haemodialysis Concentrates Sales by Type (2017-2028)
9.1.2 Latin America Haemodialysis Concentrates Revenue by Type (2017-2028)
9.2 Latin America Haemodialysis Concentrates Market Size by Application
9.2.1 Latin America Haemodialysis Concentrates Sales by Application (2017-2028)
9.2.2 Latin America Haemodialysis Concentrates Revenue by Application (2017-2028)
9.3 Latin America Haemodialysis Concentrates Market Size by Country
9.3.1 Latin America Haemodialysis Concentrates Sales by Country (2017-2028)
9.3.2 Latin America Haemodialysis Concentrates Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Haemodialysis Concentrates Market Size by Type
10.1.1 Middle East and Africa Haemodialysis Concentrates Sales by Type (2017-2028)
10.1.2 Middle East and Africa Haemodialysis Concentrates Revenue by Type (2017-2028)
10.2 Middle East and Africa Haemodialysis Concentrates Market Size by Application
10.2.1 Middle East and Africa Haemodialysis Concentrates Sales by Application (2017-2028)
10.2.2 Middle East and Africa Haemodialysis Concentrates Revenue by Application (2017-2028)
10.3 Middle East and Africa Haemodialysis Concentrates Market Size by Country
10.3.1 Middle East and Africa Haemodialysis Concentrates Sales by Country (2017-2028)
10.3.2 Middle East and Africa Haemodialysis Concentrates Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Rockwell Medical
11.1.1 Rockwell Medical Corporation Information
11.1.2 Rockwell Medical Overview
11.1.3 Rockwell Medical Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Rockwell Medical Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Rockwell Medical Recent Developments
11.2 Nipro
11.2.1 Nipro Corporation Information
11.2.2 Nipro Overview
11.2.3 Nipro Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Nipro Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Nipro Recent Developments
11.3 MEDIVATORS
11.3.1 MEDIVATORS Corporation Information
11.3.2 MEDIVATORS Overview
11.3.3 MEDIVATORS Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 MEDIVATORS Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 MEDIVATORS Recent Developments
11.4 Dialysis Medical Solutions
11.4.1 Dialysis Medical Solutions Corporation Information
11.4.2 Dialysis Medical Solutions Overview
11.4.3 Dialysis Medical Solutions Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Dialysis Medical Solutions Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Dialysis Medical Solutions Recent Developments
11.5 Fresenius Medical Care
11.5.1 Fresenius Medical Care Corporation Information
11.5.2 Fresenius Medical Care Overview
11.5.3 Fresenius Medical Care Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Fresenius Medical Care Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Fresenius Medical Care Recent Developments
11.6 Baxter
11.6.1 Baxter Corporation Information
11.6.2 Baxter Overview
11.6.3 Baxter Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Baxter Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Baxter Recent Developments
11.7 B. Braun
11.7.1 B. Braun Corporation Information
11.7.2 B. Braun Overview
11.7.3 B. Braun Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 B. Braun Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 B. Braun Recent Developments
11.8 Renacon Pharma
11.8.1 Renacon Pharma Corporation Information
11.8.2 Renacon Pharma Overview
11.8.3 Renacon Pharma Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Renacon Pharma Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Renacon Pharma Recent Developments
11.9 Surni Group
11.9.1 Surni Group Corporation Information
11.9.2 Surni Group Overview
11.9.3 Surni Group Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Surni Group Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Surni Group Recent Developments
11.10 Weigao Group
11.10.1 Weigao Group Corporation Information
11.10.2 Weigao Group Overview
11.10.3 Weigao Group Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Weigao Group Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Weigao Group Recent Developments
11.11 BIOLIGHT
11.11.1 BIOLIGHT Corporation Information
11.11.2 BIOLIGHT Overview
11.11.3 BIOLIGHT Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 BIOLIGHT Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 BIOLIGHT Recent Developments
11.12 Taishikang
11.12.1 Taishikang Corporation Information
11.12.2 Taishikang Overview
11.12.3 Taishikang Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Taishikang Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Taishikang Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Haemodialysis Concentrates Industry Chain Analysis
12.2 Haemodialysis Concentrates Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Haemodialysis Concentrates Production Mode & Process
12.4 Haemodialysis Concentrates Sales and Marketing
12.4.1 Haemodialysis Concentrates Sales Channels
12.4.2 Haemodialysis Concentrates Distributors
12.5 Haemodialysis Concentrates Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Haemodialysis Concentrates Industry Trends
13.2 Haemodialysis Concentrates Market Drivers
13.3 Haemodialysis Concentrates Market Challenges
13.4 Haemodialysis Concentrates Market Restraints
14 Key Findings in The Global Haemodialysis Concentrates Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の血液透析濃縮物市場インサイト及び予測（重炭酸塩濃縮物、酸濃縮物）(Global Haemodialysis Concentrates Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の血液透析濃縮物市場インサイト及び予測（重炭酸塩濃縮物、酸濃縮物）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp